Different sampling time points and Blinding [Bioanalytics]

posted by Pharma_88 – India, 2020-12-11 06:22 (1623 d 14:35 ago) – Posting: # 22138
Views: 3,974

Dear all,

Please provide your suggestion for below concern.

for the bioequivalence studies, Analyst is always blind despite of regulatory requirement. By keeping different sampling time points i.e. 20 time-points for test and 22 time points for reference, whether analyst will blind in this condition?

Edit: Category changed; see also this post #1. [Helmut]
—
Regards,
Pharma_88

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,680 registered users;
54 visitors (0 registered, 54 guests [including 13 identified bots]).
Forum time: 21:58 CEST (Europe/Vienna)

Being really good at C++ is like being really good
at using rocks to sharpen sticks.    Thant Tessman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5